Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-04-2024 | Levetiracetam | Clinical study

Levetiracetam-related AEs reported to FAERS

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Treatment with levetiracetam (LEV) is associated with rhabdmyolysis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, and spontaneous abortion, according to findings of a study published in Seizure – European Journal of Epilepsy.
Metadata
Title
Levetiracetam-related AEs reported to FAERS
Publication date
01-04-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55841-4

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Cotrimoxazole

Case report

Multiple drugs

Case report

Antineoplastics

Case report

Sumatriptan